Drug
tarlatamab-dlle
Marketed as IMDELLTRA (AMG757).
Generic name
tarlatamab-dlle
Brand names
IMDELLTRA (AMG757)
First FDA approval
2024-05-16
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761344 | IMDELLTRA (AMG757) | 2024-05-16 | AMGEN INC |
Manufacturers
AMGEN INC
Frequently asked questions
When was tarlatamab-dlle FDA approved?
Earliest FDA approval on record: 2024-05-16.
What brand names are sold as tarlatamab-dlle?
IMDELLTRA (AMG757).
Sources
Appeal a tarlatamab-dlle denial
Upload the denial notice. DenialHelp helps verify the reason, organize source-linked evidence, and prepare a treating-clinician-reviewable package. Price and refund terms are shown before payment.
Get started →Contact: hello@denialhelp.com